arginine vasopressin has been researched along with Carcinoma, Bronchogenic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DELAERE, J; DESOUSA, RC; MACH, RS; RUDLER, JC | 1 |
HUTTON, I; LINTON, AL | 1 |
Brown, JJ; Fox, R; Lever, AF; Morton, JJ; Padfield, PL; Robertson, JI; Wood, M | 1 |
Colburn, NH; Gindhart, TD; Hegameyer, GA; Nakamura, Y; Smith, BM; Stevens, LA; West, MW | 1 |
4 other study(ies) available for arginine vasopressin and Carcinoma, Bronchogenic
Article | Year |
---|---|
[APROPOS OF A CASE OF BRONCHIAL CARCINOMA AND SCHWARTZ-BARTTER SYNDROME. DEMONSTRATION OF AN ANTIDIURETIC ACTIVITY AT THE LEVEL OF THE TUMOR].
Topics: Arginine Vasopressin; Bronchial Neoplasms; Carcinoma, Bronchogenic; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphatic Metastasis; Natriuresis; Neoplasms; Physiology; Urine; Vasopressins | 1965 |
HYPONATRAEMIA AND BRONCHIAL CARCINOMA: THERAPY WITH NITROGEN MUSTARD.
Topics: Arginine Vasopressin; Bronchial Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Drug Therapy; Fluids and Secretions; Humans; Hyponatremia; Mechlorethamine; Neoplasms; Urine; Vasopressins | 1965 |
Plasma arginine vasopressin in the syndrome of antidiuretic hormone excess associated with bronchogenic carcinoma.
Topics: Adult; Aged; Arginine Vasopressin; Carcinoma, Bronchogenic; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Osmolar Concentration; Syndrome; Vasopressins; Water Deprivation | 1976 |
Genes and signal transduction in tumor promotion: conclusions from studies with promoter resistant variants of JB-6 mouse epidermal cells.
Topics: Animals; Arginine Vasopressin; Carcinogens; Carcinoma, Bronchogenic; Cell Line; Cell Transformation, Neoplastic; Cocarcinogenesis; Heat-Shock Proteins; Mice; Oncogenes; Oxidation-Reduction; Phosphatidylinositols; Protein Kinase C; Protein Kinases; Skin Neoplasms; Stress, Physiological; Tetradecanoylphorbol Acetate; Transduction, Genetic | 1985 |